Dr Pouya Faridi is the head of the Translational Antigen Discovery Laboratory at the School of Clinical Sciences, Monash University. After completing his pharmacy doctorate and PhD at the Shiraz University of Medical Sciences, Iran, he joined Prof Ruedi Aebersold’s laboratory at Institute for Molecular Systems Biology at the ETH Zurich, Switzerland. In 2016, he moved to Australia and joined Prof Tony Purcell’s lab at Biomedicine Discovery Institute, Monash University. In 2021, he established his own laboratory at the Department of Medicine, Monash University.

Dr Faridi has developed several mass-spectrometry and proteomics technologies to identify and quantify peptides, proteins, and metabolites. He has applied these technologies to identify and validate actionable targets for cancer immunotherapy. Some of the peptides he identified are currently used for cancer vaccination clinical studies. In addition to his research lab, Dr Faridi is the co-director of the Monash Clinical Proteomics Facility.

Dr Faridi’s research excellence is shown by the mid-career fellowship from the Victorian Cancer Agency for the development of precision vaccines for devastating paediatric brain tumours. He has several patents in the antigen discovery field, and his research has been published in prestigious journals, including Cell, Science Immunology, Nature Communications and Cancer Immunology Research. Faridi lab is supported by NHMRC, Cancer Australia, Australian Melanoma Research Foundation and Isabella & Marcus Foundation.